Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years

Diabetes Care

Volumn 26, Issue 4, 2003, Pages 1241-1245

  Kallio, Milla ^a   Forsblom, Carol ^a   Groop, Per Henrik ^a,c   Groop, Leif ^b   Lepäntalo, Mauri ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK FACTOR; TREATMENT OUTCOME; URINALYSIS;

AGE OF ONSET; ARTERIAL OCCLUSIVE DISEASES; BRACHIAL ARTERY; C-PEPTIDE; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; SMOKING; SURVIVAL RATE; TIME FACTORS; TRIGLYCERIDES;

EID: 0042167471     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.4.1241     Document Type: Article

References (34)

1. Estes JM, Pomposelli FB Jr: Lower extremity arterial reconstruction in patients with diabetes mellitus. Diabet Med 13:S43-S57, 1996
2. Beach KW, Bedford GR, Bergelin RO, Martin DC, Vandenberghe N, Zaccardi M, Strandness DE Jr: Progression of low-erextremity arterial occlusive disease in type II diabetes mellitus. Diabetes Care 11:464-472, 1988
3. Palumbo PJ, O'Fallon WM, Osmundson PJ, Zimmerman BR, Langworthy AL, Kazmier FJ: Progression of peripheral occlusive arterial disease in diabetes mellitus: what factors are predictive? Arch Intern Med 151:717-721, 1991
4. Bendick PJ, Glover JL, Kuebler TW, Dilley RS: Progression of atherosclerosis in diabetics. Surgery 93:834-838, 1983
5. Forrest KY-Z, Becker DJ, Kuller LH, Wolfson SK, Orchard TJ: Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 148:159-169, 2000
6. Vogt MT, McKenna M, Wolfson SK, Kuller LH: The relationship between ankle brachial index, other atherosclerotic disease, diabetes, smoking and mortality in older men and women. Atherosclerosis 101:191-202, 1993
7. Leng GC, Fowkes FGR, Lee AJ, Dunbar J, Housley E, Ruckley CV: Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 313:1440-1444, 1996
8. Marinelli MR, Beach KW, Glass MJ, Primozich JF, Strandness DE Jr: Noninvasive testing vs clinical evaluation of arterial disease: a prospective study. JAMA 241: 2031-2034, 1979
9. Lepäntalo M, Kangas T, Pietilä J, Scheinin T, Scheinin TM: Non-invasive characterisation of angiopathy in the diabetic foot. Eur J Vasc Surg 2:41-45, 1988
10. Emanuele MA, Buchanan BJ, Abraira C: Elevated leg systolic pressures and arterial calcification in diabetic occlusive vascular disease. Diabetes Care 4:289-292, 1981
11. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Series, No. 727)
12. Faber OK, Binder C: C-peptide response to glucagon: a test for the residual β-cell function in diabetes mellitus. Diabetes 26: 605-610, 1977
13. Heding LG: Radioimmunological determination of human C-peptide in serum. Diabetologia 11:541-548, 1975
14. Sane T, Nikkilä EA: Very low density lipoprotein triglyceride metabolism in relatives of hypertriglyceridemic probands: evidence for genetic control of triglyceride removal. Arteriosclerosis 8:217-226, 1988
15. TASC Working Group: Epidemiology, natural history, risk factors: in management of peripheral arterial disease (PAD): TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31:S5-S35, 2000
16. Takolander R, Rauwerda JA: The use of non-invasive vascular assessment in diabetic patients with foot lesions. Diabet Med 13:S39-S42, 1996
17. Orchard TJ, Strandness EJ Jr: Assessment of peripheral vascular disease in diabetes. Diabetes Care 16:1199-1209, 1993
18. Mackaay AJC, Beks PJ, Dur AHM, Bischoff M, Scholma J, Heine RJ, Rauwerda JA: The distribution of peripheral vascular disease in a Dutch Caucasian population: comparison of type II diabetic and nondiabetic subjects. Eur J Vasc Endovasc Surg 9:170-175, 1995
19. Carter SA: Role of pressure measurement in vascular disease. In Non-Invasive Diagnostic Techniques in Vascular Disease. 3rd ed. Bernstein EF, Ed. St. Louis, MO, CV Mosby, 1985, p. 513-544
20. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S: The electrocardiogram in population studies: a classification system. Circulation 21:1160-1175, 1960
21. Nielsen PE, Barras J-P, Holstein P: Systolic pressure amplification in the arteries of normal subjects. J Clin Lab Invest 33:37-1377, 1974
22. Lepäntalo M, Lindfors O, Pekkola P: The ankle/arm systolic blood pressure ratio as a screening test for arterial insufficiency in the lower limb. Ann Chir Gyn 72:57-62, 1983
23. Carter SA: Indirect systolic pressures and pulse waves in arterial occlusive disease of the lower extremities. Circulation 37:624-637, 1968
24. Janka HU, Standl E, Mehnert H: Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with Doppler ultrasonic technique. Diabetes Care 3:207-213, 1980
25. MacGregor AS, Price JF, Hau CM, Lee AJ, Carson MN, Fowkes FGR: Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease: the Edinburgh Artery Study. Diabetes Care 22:453-458, 1999
26. Beach KW, Strandness JRE: Arteriosclerosis obliterans and associated risk factors in insulin-dependent and non-insulin-dependent diabetes. Diabetes 29:882-888, 1980
27. Fowkes FGR, Housley E, Cawood EHH, Macintyre CCA, Ruckley CV, Prescott RJ: Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20:384-392, 1991
28. Schroll M, Munck O: Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women. J Chron Dis 36:261-269, 1981
29. Osmundson PJ, O'Fallon WM, Zimmerman BR, Kazmier FJ, Langworthy AL, Palumbo PJ: Course of peripheral arterial disease in diabetes: vascular laboratory assessment. Diabetes Care 13:143-152, 1990
30. Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC (Eds.): How to prevent foot problems. In International Consensus on the Diabetic Foot. Amsterdam, International Working Group on the Diabetic Foot, 1999, p. 66
31. Mattock MB, Morrish NJ, Viberti GC, Keen H, Fitzgerald AP, Jackson G: Prospective study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes 41:736-741, 1992
32. Jarret RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrels TJ: Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabet Med 1:17-19, 1983
33. Groop PH: Lipidemia and diabetic renal disease. In The Kidney and Hypertension in Diabetes Mellitus. 4th ed. Mogensen CE, Ed. Boston, MA, Kluwer Academic, 1998, p. 357-369
34. Migdalis IN, Dimakopoulos N, Kourti A, Tolis A, Koutoulidis K, Samartzis M: The prevalence of peripheral vascular disease in type 2 diabetic patients with and without proteinuria. Int Angiol 13:229-232, 1994